DAMPs, PAMPs and alarmins: All we need to know about danger

Journal of Leukocyte Biology

Volumn 81, Issue 1, 2007, Pages 1-5

  Bianchi, Marco E ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Immunity; Inflammation; RAGE; TLR

Indexed keywords

ALARMIN; ALARMIN RECEPTOR; CELL PROTEIN; HEAT SHOCK PROTEIN; HEPATOMA DERIVED GROWTH FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; NUCLEAR PROTEIN; PROTEIN S 100; UNCLASSIFIED DRUG; URIC ACID;

ARTICLE; CELL DAMAGE; EFFECTOR CELL; MOLECULE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE INJURY;

ANIMALS; CALGRANULIN A; HEAT-SHOCK PROTEINS; HMGB1 PROTEIN; INTERLEUKIN-1ALPHA; MICE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; URIC ACID;

METAZOA;

EID: 33845951211     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0306164     Document Type: Article

References (58)

1. Janeway, C. A., Jr., Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
2. Agresti, A., Bianchi, M. E. (2003) HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 13, 170-178.
3. Müller, S., Ronfani, L., Bianchi, M. E. (2004) Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J. Intern. Med. 255, 332-343.
4. Scaffidi, P., Misteli, T., Bianchi, M. E. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195.
5. Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., Rubartelli, A. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 995-1001.
6. Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., Bianchi, M. E. (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22, 5551-5560.
7. Semino, C., Ceccarelli, J., Lotti, L.V., Torrisi, M.R., Angelini, G., Rubartelli, A. (2007) The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J. Leukoc. Biol. 81, 92-99.
8. Rauvala, H., Merenmeri, J., Pihlaskari, R., Korkolainen, M., Huhtala, M.-L., Panula, P. (1988) The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons. J. Cell Biol. 107, 2293-2305.
9. Liu, S., Stolz, D.B., Sappington, P.L., Macias, C.A., Killeen, M.E., Tenhunen, J.J., Delude, R.L., Fink, M.P. (2006) HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am. J. Physiol. Cell Physiol. 290, C990-9.
10. Porto, A., Palumbo, R., Pieroni, M., Aprigliano, G., Chiesa, R., Sanvito, F., Maseri, A., Bianchi, M. E. (2006) Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to High Mobility Protein Box 1. FASEB J., 20, E1-E9.
11. Wahamaa, H., Vallerskog, T., Qin, S., Lunderius, C., Larosa, G., Andersson, U., Erlandsson-Harris, H. (2007) HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay. J. Leukoc. Biol. 81, 129-136.
12. Ito, N., Demarco, R.A., Mailliard, R.B., Han, J., Rabinowich, H., Kalinski, P., Stolz, D.B., Zeh, H.J., Lotze, M.T. (2007) Cytolytic cells induce HMGB1 release from melanoma cell lines. J. Leukoc. Biol. 81, 75-83.
13. Qin, S., Wang, H., Yuan, R., Li, H., Ochani, M., Ochani, K., Rosas-Ballina, M., Czura, C. J., Huston, J. M., Miller, E., et al. (2006) Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203, 1637-1642.
14. Dumitriu, I. E., Baruah, P., Manfredi, A. A., Bianchi, M. E., Rovere-Querini, P. (2005) HMGB1: guiding immunity from within. Trends Immunol. 26, 381-387.
15. Yang, D., Chen, Q., Yang, H., Tracey, K.J., Bustin, M., Oppenheim, J.J. (2006) High mobility group box-1 (HMGB1) protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81, 59-66.
16. Dumitriu, I.E., Bianchi, M.E., Bacci, M., Manfredi, A.A., Rovere-Querini, P. (2007) The secretion of HMGB1 is required for the migration of maturing dendritic cells. J. Leuk. Biol. 81, 84-91.
17. Degryse, B., Bonaldi, T., Scaffidi, P., Muller, S., Resnati, M., Sanvito, F., Arrigoni, G., Bianchi, M. E. (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152, 1197-1206.
18. Sappington, P. L., Yang, R., Yang, H., Tracey, K. J., Delude, R. L., Fink, M. P. (2002) HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123, 790-802.
19. Mitola, S., Belleri, M., Urbinati, C., Coltrini, D., Sparatore, B., Pedrazzi, M., Melloni, E., Presta, M. (2006) Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 176, 12-15.
20. Dumitriu, I. E., Baruah, P., Bianchi, M. E., Manfredi, A. A., Rovere-Querini, P. (2005) Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur. J. Immunol. 35, 2184-2190.
21. Rovere-Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I. E., Muller, S., Iannacone, M., Traversari, C., et al. (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5, 825-830.
22. Messmer, D., Yang, H., Telusma, G., Knoll, F., Li, J., Messmer, B., Tracey, K. J., Chiorazzi, N. (2004) High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173, 307-313.
23. Palumbo, R., Sampaolesi, M., De Marchis, F., Tonlorenzi, R., Colombetti, S., Mondino, A., Cossu, G., Bianchi, M. E. (2004) Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164, 441-449.
24. Limana, F., Germani, A., Zacheo, A., Kajstura, J., Di Carlo, A., Borsellino, G., Leoni, O., Palumbo, R., Battistini, L., Rastaldo, R., et al. (2005) Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ. Res. 97, e73-e83.
25. Germani, A., Limana, F., Capogrossi, M.C. (2006) Pivotal Advance: High-mobility group box 1 protein - a cytokine with a role in cardiac repair. J. Leukoc. Biol. 81: 41-45.
26. Hori, O., Yan, S. D., Ogawa, S., Kuwabara, K., Matsumoto, M., Stern, D., Schmidt, A. M. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J. Biol. Chem. 270, 25752-25761.
27. Andersson, U., Wang, H., Palmblad, K., Aveberger, A. C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192, 565-570.
28. Erlandsson-Harris, H., Raucci, A. (2006) Alarmin(g) news about danger. Workshop on Innate Danger Signals and HMGB1. EMBO Rep. 7, 774-778.
29. Rouhiainen, A., Tumova, S., Valmu, L., Kalkkinen, N., Rauvala, H. (2006) Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (Amphoterin). J. Leukoc. Biol. 81, 49-58.
30. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. Y., Strassheim, D., Ishizaka, A., Abraham, E. (2004) Involvement of TLR2 and TLR4 in cellular activation by high mobility group box 1 protein (HMGB1). J. Biol. Chem. 279, 7370-7377.
31. Foell, D., H., W., Vogl, T., Roth, J. (2007) S100 proteins expressed in phagocytes: a novel group of Damage Associated Molecular Pattern molecules. J. Leukoc. Biol. 81: 28-37.
32. Bianchi, R., Adami, C., Giambanco, I., Donato, R. (2006) S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 81, 108-118.
33. Zhou, Z., Yamamoto, Y., Sugai, F., Yoshida, K., Kishima, Y., Sumi, H., Nakamura, H., Sakoda, S. (2004) Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus. J. Biol. Chem. 279, 27320-27326.
34. Schmitt, E., Gehrmann, M., Brunet, M., Multhoff, G., Garrido, C. (2007) Intracellular and extracellular functions of Heat Shock Proteins: Repercussions in cancer therapy. J. Leukoc. Biol. 81, 15-27.
35. Werman, A., Werman-Venkert, R., White, R., Lee, J. K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C. A., Apte, R. N. (2004) The precursor form of IL-1α is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 101, 2434-2439.
36. Shi, Y., Evans, J. E., Rock, K. L. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521.
37. Shi, Y., Galusha, S. A., Rock, K. L. (2006) Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176, 3905-3908.
38. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., Tschopp, J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241.
39. Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., Nawroth, P. P. (2005) Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83, 876-886.
40. Salmivirta, M., Rauvala, H., Elenius, K., Jalkanen, M. (1992) Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp. Cell Res. 200, 444-451.
41. Tsung, A., Zheng, N., Jeyabalan, G., Izuishi, K., R., K.J., Geller, D.A., Lotze, M.T., Lu, L., Billiar, T.R. (2007) Increasing numbers of hepatic dendritic cells promote HMGB1 mediated ischemia-reperfusion injury. J. Leukoc. Biol. 81, 119-128.
42. Abeyama, K., Stern, D. M., Ito, Y., Kawahara, K. I., Yoshimoto, Y., Tanaka, M., Uchimura, T., Ida, N., Yamazaki, Y., Yamada, S., et al. (2005) The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest. 115, 1267-1274.
43. Urbonaviciute, V., Fürnrohr, B.G., Weber, C., Haslbeck, M., Wilhelm, S., Herrmann, M., Voll, R.E. (2007) Factors masking HMGB1 in human serum and plasma. J. Leukoc. Biol. 81, 67-74.
44. Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101, 296-301.
45. Taniguchi, N., Kawahara, K., Yone, K., Hashiguchi, T., Yamakuchi, M., Goto, M., Inoue, K., Yamada, S., Ijiri, K., Matsunaga, S., et al. (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48, 971-981.
46. Kokkola, R., Li, J., Sundberg, E., Aveberger, A. C., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., Harris, H. E. (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48, 2052-2058.
47. Popovic, K., Ek, M., Espinosa, A., Padyukov, L., Harris, H. E., Wahren-Herlenius, M., Nyberg, F. (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 52, 3639-3645.
48. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) Blockage of RAGE-amphoterin signalling suppresses tumour growth and metastasis. Nature 405, 354-360.
49. Sitia, G., Iannacone, M., Müller, S., Bianchi, M.E., Guidotti, L.G. (2007) Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J. Leukoc. Biol. 81, 100-107.
50. Zenz, R., Eferl, R., Kenner, L., Florin, L., Hummerich, L., Mehic, D., Scheuch, H., Angel, P., Tschachler, E., Wagner, E. F. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437, 369-375.
51. Oppenheim, J. J., Yang, D. (2005) Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365.
52. Liu, F. T., Rabinovich, G. A. (2005) Galectins as modulators of tumour progression. Nat. Rev. Cancer 5, 29-41.
53. Goldstein, A. L., Hannappel, E., Kleinman, H. K. (2005) Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 11, 421-429.
54. Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., Ruoslahti, E. (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell Biol. 163, 871-878.
55. 2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6, 449-461.
56. Munoz, L.E., Franz, S., Pausch, F., Furnrohr, B., Sheriff, A., Vogt, B., Kern, P.M., Baum, W., Stach, C., von Laer, D., Brachvogel, B., Poschl, E., Herrmann, M., Gaipl, U.S. (2006) The influence on the immunomodulatory effects of dying and dead cells of Annexin V. J. Leukoc. Biol. 81, 6-14.
57. Bianchi, M. E. (2004) Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol. 14, 287-293.
58. Seong, S. Y., Matzinger, P. (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478.